Methaddict 80 mg
Methaddict 80 mg is a medicine authorised by Swissmedic under authorisation number 69406. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is A+: Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material. First authorisation was granted on 14 July 2023 and the authorisation is limited until 13 July 2028. ATC code N07BC02 places the medicine in the group Other nervous system drugs.
| Authorisation number | 69406 |
|---|---|
| Name | Methaddict 80 mg |
| Full name | Methaddict 80 mg, Tabletten |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A+ · Prescription with conditions |
| ATC code | N07BC02 |
| First authorisation | 14 July 2023 |
| Authorisation validity | 13 July 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Methaddict 80 mg, Tabletten | A+ | 14 July 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 20 | Tablette(n) | N07BC02 | 01.01.3. | A+ |
| 2 | 50 | Tablette(n) | N07BC02 | 01.01.3. | A+ |
| 3 | 70 | Tablette(n) | N07BC02 | 01.01.3. | A+ |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Methaddict 80 mg authorised in Switzerland?
Yes. Methaddict 80 mg is authorised by Swissmedic under authorisation number 69406, data as of 01 September 2026. The authorisation is limited until 13 July 2028.
Which dispensing category does Methaddict 80 mg have?
Methaddict 80 mg is in dispensing category A+. Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material.
Who is the authorisation holder of Methaddict 80 mg?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.